# Autoimmunity in Inner Ear Disease

> **NCT00000361** · PHASE3 · TERMINATED · sponsor: **National Institute on Deafness and Other Communication Disorders (NIDCD)**

## Conditions studied

- Hearing Loss, Sensorineural

## Interventions

- **DRUG:** Corticosteroids
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00000361
- **Lead sponsor:** National Institute on Deafness and Other Communication Disorders (NIDCD)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-03
- **Primary completion:** —
- **Final completion:** 2002-11
- **Target enrollment:** — (—)
- **Last updated:** 2006-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000361, "Autoimmunity in Inner Ear Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*